T
here is currently no gold standard for the diagnosis of shock. Unfortunately, patients may have inadequate regional organ oxygen delivery despite apparently adequate systemic perfusion parameters. Traditional methods of identifying shock such as blood pressure, arterial base deficit (BD), serum lactate, and mixed venous oxygen saturation (SvO 2 ) carry inherent flaws in their application and their practicality. 1 Blood pressure changes may not occur until significant blood loss has occurred. Furthermore, patients who are thought to be fully resuscitated when resuscitation is directed by blood pressure alone may have a markedly inadequate intravascular volume. In this state of hypoperfusion, tissue ischemia may lead to increased morbidity and mortality as a result of multiple organ dysfunction syndrome (MODS).
Laboratory markers for assessing the presence of shock such as BD and serum lactate also have limitations. These measures may be normal in early hemorrhagic shock and can be altered by pre-existing medical conditions. In addition, it is quite difficult to obtain these tests in field conditions and intermittent blood sampling is required. SvO 2 measurement mandates central venous access and placement of a pulmonary artery catheter. The clinical value of SvO 2 is limited because it reflects global assessment of the adequacy of tissue perfusion. Thus, an early detector of shock is critically needed.
Near-infrared spectroscopy (NIRS) permits continuous, noninvasive measurement of tissue hemoglobin oxygen saturation (StO 2 ) in muscle and has been evaluated in a wide range of human conditions. [2] [3] [4] [5] [6] In trauma care, research is currently focused on determining the clinical utility of monitoring peripheral muscle oxygenation in hemorrhagic shock. 1 We conducted this prospective study to investigate the association between StO 2 and hemorrhagic shock. The primary study objective was to analyze whether there was a relationship between early measurements of StO 2 and subsequent adverse outcomes. There is evidence that MODS is a consequence of hypoperfusion. 7, 8 Therefore, we selected post-traumatic MODS as the primary endpoint of interest. We endeavored to determine the StO 2 threshold that would provide the greatest sensitivity and specificity for the prediction of MODS. A population at risk for MODS (major torso trauma patients presenting in shock, requiring early blood transfusion) was enrolled and StO 2 data were collected. We hypothesized that information derived from an NIRS device placed on a peripheral muscle would reliably identify clinically relevant hypoperfusion, subsequently manifested as MODS.
PATIENTS AND METHODS
This multi-center, prospective, nonrandomized cohort study was conducted at seven Level I trauma centers between October 2004 and February 2006.
Patients
The sample population included adult patients, age 18 years and older, who arrived in the emergency department (ED) within 6 hours of injury, had evidence of shock (systolic blood pressure [SBP] Ͻ90 mm Hg before, or within 1 hour, after arrival or BD Ն6 mEq/L within 1 hour after arrival) and had at least one of the following: pelvic fracture, one or more long bone fractures, multiple rib fractures or pulmonary contusion, or major blunt or penetrating torso trauma. All study patients were anticipated to require blood transfusion within 12 hours after arrival. Patients had to have sufficient intact skin on a thenar eminence to accommodate placement of the StO 2 sensor (InSpectra Tissue Spectrometer, Hutchinson Technology Inc., Hutchinson, Minn.). Patients were excluded from the study if they had an admission Glasgow Coma Scale score of Յ4 in the absence of medications to induce sedation or paralysis, cardiac arrest before, or at arrival in the ED, penetrating or nonsurvivable brain injury, advanced directive limiting aggressive care, bilateral upper extremity fractures, amputations or hematoma over both thenar eminences, or if they were enrolled in a red blood cell substitute clinical trial.
In February 2005, interim analysis among the first 39 enrolled patients revealed a MODS rate of only 7.7%. Moreover, 21% of the patients did not meet clinical criteria for Intensive Care Unite (ICU) admission. The enrollment criteria were subsequently amended to include a blood transfusion requirement within 6 hours of ED arrival, removal of the prehospital requirement for SBP Ͻ90 mm Hg and an increase of the number of long bone fractures required to Ն2. Of the 95 patients who were enrolled under the original study criteria, 34 met the more rigorous new criteria.
Although each study site endeavored to provide research staff to enable screening and enrollment 24 hours a day each day of the week, not all eligible patients were enrolled because of limitations in the availability of staff and NIRS monitors. The study sample, therefore, was a random sample of consecutive patients available for enrollment in the study.
Human patients approval was obtained from each participating center. Because of the minimal risk nature of the study and the inability of critically injured trauma patients (or their surrogate) to provide consent within minutes of ED arrival, Institutional Review Boards (IRBs) either granted a waiver of consent or permitted consent to be obtained after StO 2 monitoring began.
Study Protocol
The thenar StO 2 sensor was placed within 30 minutes of ED arrival and remained in place for 24 hours or until death or discharge if earlier. StO 2 was continuously monitored with data captured on a bedside laptop computer. StO 2 measurements were not made available to the investigators, and therefore the study had no impact on the usual care provided to the patients.
StO 2 Measurements
For purposes of evaluating the predictive utility of StO 2 in identifying patients at risk for later adverse sequelae, we used the minimum StO 2 readings during the first 60 minutes of monitoring. The physiologic foundation for minimum StO 2 rests on the theory that peripheral hypoperfusion is a marker for worsening patient condition as it coincides with the body's shunting of blood to the internal organs and away from the periphery. 9 The InSpectra device collects StO 2 values every 3.5 seconds, and for this analysis we created an algorithm to provide the time-averaged StO 2 during each minute of monitoring.
StO 2 threshold values were assessed as part of a planned analysis. BD and SBP threshold values were selected because they are routinely used in the management of trauma patients. To provide further support for the relationship between impaired tissue perfusion as measured by StO 2 and MODS, we also evaluated the clinical utility of area sum 70. This parameter is the difference between the area above and below a horizontal line drawn at 70% StO 2 created by the StO 2 curve throughout time. It represents both the magnitude and duration of hypoperfusion during the first 60 minutes of hospitalization.
StO 2 was collected on the thenar eminence adjacent to the site of radial artery cannulation for varying durations in 34 patients. The effect of radial artery cannulation on StO 2 is not well understood and therefore StO 2 values collected under these conditions were removed from the analysis.
Study Objectives
The chief objective of this study was to determine whether a relationship existed between StO 2 and the development of MODS. A secondary objective was to assess the utility of StO 2 in predicting 28-day mortality. In addition, the area under the receiver operating characteristic (ROC) curve, sensitivity, specificity, positive, and negative predictive value for BD and SBP were calculated for qualitative comparison to StO 2.
MODS Assessment
The degree of organ dysfunction was evaluated daily for the first 14 days using the MOD score. 7 Patients were assumed to have met criteria for MOD when the MOD score was Ն6. Consistent with prior work, the first 72 hours were censored for multiple organ failure as any physiologic derangements at this early time point were assumed to be the result of catastrophic injury and were not thought to represent the consequences of prolonged organ dysfunction. We modified the MOD score by eliminating the GCS (as mentation could have been impacted by underlying brain injury), but scored organ dysfunction in the other five organs systems as originally described; respiratory, renal, hepatic, cardiovascular, and hematologic systems. In addition, we used the worst score calculated on a daily basis rather than the worst organ system score summation during the entire ICU period. The rationale for the 14-day cutoff was based on the known temporal distribution of organ dysfunction. 8 
Mortality Assessment
Dates and causes of deaths were recorded for those that occurred between study enrollment and on or before the 28th day after hospital admission. Patients discharged from the hospital before day 28 were contacted or assessed via medical record review on day 29, or later, to verify their status. If they were not reached at the initial contact, an additional contact was attempted.
Clinical Assessment
The study collected prehospital data including injury date, time, mechanism and cause, arrival time at and departure time from referring hospitals, lowest blood pressure, quantity of intravenous fluids and transfused blood, and the occurrence of intubation and classes of medications administered. In the first hour after ED arrival, pulse oximetry; systolic and diastolic blood pressure; mean arterial blood pressure and heart rate were recorded a minimum of every 15 minutes, or more frequently as warranted by the patient's clinical status. During the initial 24 hours after ED arrival while StO 2 was monitored, all measurements of blood pressure, heart rate, pulse oximetry, body temperature, aterial blood gases including BD, serum lactate, hemoglobin or hematocrit, platelet count, prothrombin time, partial thromboplastin time, international normalized ratio (INR), central venous pressure, SvO 2 , pulmonary capillary wedge pressure, cardiac index, oxygen delivery, oxygen consumption, and systemic vascular resistance were recorded as often as clinically assessed. Likewise, medication administration, hourly totals of intravenous fluids and blood products and operative and diagnostic procedures in the first 24 hours were recorded. Age, gender, height, weight, and history of comorbidities were also collected. Injury Severity Score (ISS) data were obtained from the participating centers' trauma registry databases. Acute Physiology and Chronic Health Evaluation (APACHE) II scores were determined from the worst values recorded during the first 24 hours of ICU admission.
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Statistical Methods
The study was powered to detect an area under the receiver operating characteristic curve (AUC) value that was consistent with the performance of BD. A cutoff Ն8 mEq/L for BD in the first 12 hours after admission has been shown to have a sensitivity of 0.85 with a specificity 0.45, i.e. an AUC BD ϭ 0.65. 8 This study was designed to determine whether the AUC for StO 2 with respect to MODS was greater than 0.50. In high-risk trauma patients, the incidence of multiple organ failure ranges from 14% to 42%. 8 Setting the one-sided type I error rate at 0.025, power at 80%, and accounting for an interim analysis, required that the study would enroll 35 MODS patients at the time of the final analysis. Using the 14% rate for MODS and an attrition rate of 10%, it was initially estimated that it would be necessary to enroll up to 278 patients to achieve 35 patients that developed MODS.
Logistic regression analysis was used to estimate the AUC for MODS and mortality. Estimates of sensitivity, specificity, and positive and negative predictive values were also obtained. Wilcoxon Signed Rank and Fisher's Exact tests were used to make comparisons between outcome groups for the clinical and demographic parameters.
RESULTS
Demographics
During the enrollment period of this study, 30,630 trauma patients were seen at participating trauma centers. Of these, 8,056 had an ISS greater than 15. The study screened (StO 2 sensor applied) 1,611 patients and 383 met entry criteria.
All sites, on average, met the goal of initiating StO 2 monitoring within 30 minutes of patients' arrival in the ED The Journal of TRAUMA Injury, Infection, and Critical Care proximately 1.5 hours before ED arrival (mean ϭ 1.3 Ϯ 1.3 hours). Patients were admitted to the ICU approximately 4.5 hours after ED arrival (mean ϭ 4.5 Ϯ 2.8 hours). The median hospital length of stay was 13 days and 19% (71 out of 380) of patients remained in the hospital on day 29 of the study. Figure 1 demonstrates the outcomes in our patient population. Thirty-nine patients who died before the third day of ICU admission and two of the three individuals whose consent was withdrawn because of incarceration were not included in the MODS analysis. The incarcerated patient that was included in the analysis developed MODS before being taken into custody. Data for the incarcerated patients were included up to their arrest. Fifty patients developed MODS and 292 did not. Of the 380 patients included in the analysis of survival through day 28, 55 patients died and 325 survived. The survival status of 90% of patients (341 out of 380) was verified on day 29 of the study. The remaining 10% of patients who were known to have left the hospital alive were assumed to be alive for purposes of analysis. The 35 deaths which occurred within 24 hours of admission were primarily because of hemorrhage (80%, n ϭ 28) and brain injury (17%, n ϭ 6). The 20 deaths that occurred later in the hospitalization were most frequently because of brain injury (30%, n ϭ 6), cardiac or respiratory failure (20%, n ϭ 4), MODS (20%, n ϭ 4), or sepsis (15%, n ϭ 3). Table 1 compares the demographics and injury history of study patients. Those who had MODS were statistically significantly more likely to have had blunt mechanism of injury or to have been pedestrians struck by a motor vehicle ( p Ͻ 0.05). Patients who died or developed MODS had statistically significantly higher ISS, maximum AIS or APACHE II scores ( p Ͻ 0.05). Individuals who died were statistically significantly older and had statistically significantly higher rates of hypertension, cancer, and liver disease (Tables 1 and  2 ). The rate of unknown comorbidities was 10% to 15% across those reported. Patients with unknown comorbidity status appeared to be equally distributed between the groups with and without MODS. Table 3 presents prehospital data. There was no difference in the elapsed time between injury and study site ED arrival between patients who did and did not develop MODS or those who did and did not die. However, patients who ultimately developed MODS or died were statistically more likely to have been intubated before arrival at the study site ( p Ͻ 0.05).
MODS and Death
Clinical data within the first 60 minutes of hospitalization clearly differentiated MODS and non-MODS patients (Table 4) . Maximum heart rate and BD were higher in MODS patients as compared with non-MODS patients. Similarly, the lowest hematocrit values were statistically significantly lower in the first hour of hospitalization in MODS patients compared with non-MODS patients. Table 5 delineates patient differences during the first 6 hours of admission with regard to administration of fluids and blood products. Patients who developed MODS received statistically significantly more fluids and blood products during the first 6 hours than those who did not develop MODS ( p Ͻ 0.05). This was also evident for patients who died compared with those who survived. Patients who died were also more likely to have received a vasopressor or inotrope within the first 6 hours when compared with survivors ( p Ͻ 0.05). Most patients (76%) who developed multiple organ dysfunction, did so within the first 5 days of hospitalization (Fig. 2) . Table 6 provides statistical comparisons among the sensitivity, specificity, positive, and negative predictive values and AUC for minimum StO 2 , maximum BD and minimum SBP in the first hour after ED arrival for the development of MODS. When assessing minimum StO 2 collected within the first hour of ED arrival, the cutoff value that provided the best trade-off between sensitivity and specificity was 75%. The sensitivity of minimum StO 2 with respect to the development of MODS was estimated at 78%, the specificity at 39%, the positive predictive value at 18% and the negative predictive value at 91%. None of the statistical comparisons between maximum BD and minimum StO 2 was statistically significant indicating that the two measures performed similarly in the discrimination of MODS patients. The sensitivity for both (Table 6 ). The specificity for minimum StO 2 (cutoff ϭ 75%) was significantly higher when compared with minimum SBP (cutoff ϭ 90 mm Hg), (39% (95% CI [confidence interval]: 34, 43) versus 32% (95% CI: 27, 36), respectively, p ϭ 0.0381) for prediction of MODS. Figure 3 reveals that most deaths occurred on the first day (35 of 55 deaths), typically in the first 8 hours after ED arrival. The 20 additional cases of death were distributed evenly during the 28 days after ED arrival. Table 7 provides statistical comparisons among the sensitivity, specificity, positive, and negative predictive values and AUC for minimum StO 2 , maximum BD and minimum SBP in the first hour after ED arrival for death. Minimum StO 2 with a cutoff of 75% performed similarly with respect to mortality, with a sensitivity of 91%, a specificity of 37%, a positive predictive value of 20%, and a negative predictive value of 96% at 1 hour. In Table 7 the sensitivity of minimum StO 2 (cutoff ϭ 75%) in the first hour is significantly greater than maximum BD (cutoff ϭ 6 mEq/L) ( p ϭ 0.0175) and minimum SBP (cutoff ϭ 90 mm Hg) ( p ϭ 0.0489) in predicting death. The negative predictive value for minimum StO 2 is also significantly greater than maximum BD ( p ϭ 0.0116) and minimum SBP ( p ϭ 0.0375). Minimum StO 2 also has greater specificity than minimum SBP ( p ϭ 0.0295) in predicting mortality. Figure 4 depicts the ROC curves for MODS comparing maximum BD, minimum SBP, and minimum StO 2 in the first hour in the ED. Figure 5 depicts the ROC curves for mortality comparing maximum BD, minimum SBP, and minimum StO 2 in the first hour after arrival to the ED. The ROC curves demonstrate that maximum BD and minimum SBP have approximately the same AUC values for determining the likelihood of death or MODS. When combining our major outcomes, MODS and death, minimum StO 2 continues to perform similarly to SBP and BD in predicting the likelihood of a bad outcome (Table 8) .
StO 2 Data
Area sum 70 in the first hour was nearly identical to minimum StO 2 in the first hour in predicting MODS and mortality. The AUC for MODS was 0.689 (95% CI: 0.62, 0.76) and for mortality it was 0.713 (95% CI: 0.65, 0.78). The sensitivity of area sum 70 (using a cutoff of 8% ϫ hour) for MODS was 80%, the specificity was 47%, the positive predictive value was 21% and the negative predictive value was 93%. The sensitivity of area sum 70 (using a cutoff of 8% ϫ hour) for mortality was 80%, the specificity was 44%, the positive predictive value was 19% and the negative predictive value was 93%.
There were no device-related adverse events observed in the 383 enrolled patients who were exposed to the InSpectra The Journal of TRAUMA Injury, Infection, and Critical Care device. On average, the enrolled patients were exposed to the InSpectra system for 21 hours.
DISCUSSION
Our prior investigations lead us to think that NIRS technology could represent an early detector of hemorrhagic shock. The principal finding of this study was that NIRSderived StO 2 provided information within the first hour of ED arrival that could discriminate patients who would later go on to develop MODS or die from those who did not. In addition, StO 2 provided the same discriminatory power as BD and SBP to predict both MODS and mortality.
The NIRS device is a noninvasive monitoring system that measures an approximated value of percent hemoglobin oxygen saturation in tissue. The tissue spectrometer is indicated for use in monitoring patients during circulatory or perfusion examinations of skeletal muscle or when there is a suspicion of compromised circulation. An early version of the 
StO 2 Monitoring in Traumatic Shock
Volume 62 • Number 1NIRS device was evaluated in several preclinical and clinical studies of hemorrhagic shock resuscitation. In animal models, NIRS technology has demonstrated sensitivity in detecting skeletal muscle and visceral organ ischemia. [11] [12] [13] [14] In a porcine shock model, peripheral muscle StO 2 was more reliable than BD and SvO 2 as an indicator of hemorrhagic shock and was shown to be feasible to use as a sole endpoint of resuscitation. 15 The initial trial in acutely injured trauma patients at risk for organ failure assessed 24 patients undergoing shock resuscitation. 16 Impaired cellular oxygen utilization found early in resuscitation, as detected with a NIRS probe placed over the deltoid muscle, was proposed as a potential predictor of multiple organ dysfunction. Subsequently, other investigators compared changes in StO 2 with a series of clinical indices of resuscitation in eight severely injured trauma patients who were at risk for developing multiple organ failure. Skeletal muscle and subcutaneous tissue StO 2 were measured simultaneously over the deltoid region for 36 hours. Mean skeletal muscle StO 2 increased in parallel with oxygen delivery whereas subcutaneous StO 2 did not change during resuscitation. Skeletal muscle StO 2 correlated with oxygen delivery (r ϭ 0.95, p Ͻ 0.05) and BD (r ϭ 0.83, p Ͻ 0.05) suggesting that StO 2 may have potential value as a noninvasive indicator of resuscitation status. 17 We previously characterized the range of thenar muscle StO 2 in 707 healthy, ambulatory volunteers, whose mean age was 49, and who were 60% female. 18 Mean Ϯ SD, StO 2 was 87% Ϯ 6%. To determine whether NIRS could identify the severity of shock in trauma patients, we also measured thenar muscle StO 2 in 145 individuals undergoing evaluation and treatment in a Level I trauma center resuscitation area. A panel of experienced trauma surgeons, blinded to StO 2 values, retrospectively stratified patients into shock severity groups based on conventional physiologic and clinical data. Mean Ϯ SD, StO 2 for each group was no shock, 83 Ϯ 10% (n ϭ 98); mild shock, 83 Ϯ 10% (n ϭ 19); moderate shock, 80 Ϯ 12% (n ϭ 14); and severe shock, 45 Ϯ 26% (n ϭ 14). StO 2 discriminated normal and no shock patients from those with severe shock ( p Ͻ 0.05). Based on the ROC curves, minimum StO 2 was similar to minimum SBP (AUC ϭ 0.947 vs. 0.978) in discriminating severe from no, mild, and moderate shock. Several limitations of the study were identified. Stratification of the patient groups relied on physician interpretation of subjective evidence of the degree of shock, rather than on any objective measure of hypoperfusion. In addition, the study population was heterogeneous and data were collected during a relatively brief time period.
In the current prospective, cohort study conducted at multiple Level I trauma centers in the United States, we found that StO 2 was useful in discriminating patients who would later go on to develop MODS after major trauma from those who did not. Information from this noninvasive device compared favorably to SBP and BD in predicting which patients would develop MODS.
Comparable to SBP or BD, StO 2 appears to be a sensitive, but less specific marker of poor clinical outcomes associated with hypoperfusion. Not infrequently, hemodynamic data obtained from trauma patients are erroneous and assessment of blood pressure via noninvasive devices is erratic. Therefore, surgeon experience remains an important factor in recognizing when to resuscitate patients and when to terminate resuscitation. Assuming that further clinical practice with this device supports the findings of our study, StO 2 may prove invaluable in identifying patients with occult hypoperfusion early in their hospital course. This information could facilitate more rapid recognition of individuals who require emergent intervention. Furthermore, this monitor may help establish the adequacy of resuscitation, enabling clinicians to limit resuscitation before excessive fluids are administered.
This observational trial has a number of limitations. First, the study primarily included patients who were hypotensive at admission. Therefore, we did not investigate the entire trauma population but rather focused on the group of patients most likely to have hypoperfusion and develop organ dysfunction. Had we enrolled patients from the entire trauma population, the estimates for sensitivity and specificity may have been impacted. Second, the estimates for sensitivity and specificity based on the StO 2 threshold of 75% were optimized with respect to this data set. This cutoff was determined, based on its performance within this group of patients, as the best trade-off between sensitivity and specificity. However, the cutoff value was consistent with previous research and represents two standard deviations below the mean determined in a large number of ambulatory subjects in our earlier study. 18 Third, we did not establish the temporal relationship of the StO 2 findings and specific occurrence of hypoperfusion. Although it is possible that changes in StO 2 merely followed, rather than were associated with, major events, it is our contention, based on extensive experience in animal models, that the NIRS device is an excellent and rapid detector of muscle hypoperfusion. Fourth, although the predictive ability to determine MODS and death by StO 2 appeared to be similar to those of BD and SBP, these comparative clinical measurements were done intermittently and at the judgment of the trauma team. They were not performed continuously or at specific time points so the accuracy of their performance may have been compromised. Of the patients with at least one measurement during the first hour in the hospital, the average Ϯ SD number of BD values was 1.4 Ϯ 0.7 and the average number of SBP values was 6.4 Ϯ 2.7. Fifth, because our trial design blinded investigators to StO 2 measurements, it is not known if StO 2 would have aided clinicians in detecting patients at high risk for hypoperfusion. However, adding StO 2 to BD did improve the ability to predict the development of MODS (AUC BD ϭ 0.627, AUC StO2 ϭ 0.661, AUC BDϩStO2 ϭ 0.693). Furthermore, StO 2 alone appeared superior to SBP in its ability to predict the development of MODS (AUC SBP ϭ 0.568, AUC StO2 ϭ 0.661, AUC SBPϩStO2 ϭ 0.662). Sixth, we have yet to define how responsive StO 2 is to resuscitation, and whether these data would lead to earlier identification of patients with occult hypoperfusion or to more appropriate titration of resuscitation in patients in whom perfusion has been normalized.
It is possible that using MODS as our primary endpoint reflecting hypoperfusion was an overly rigorous definition of shock, as clearly some patients with profound blood loss who arrive in extremis never develop organ dysfunction. However, it is unlikely that many trauma patients who developed MODS failed to experience significant episodes of hypoperfusion. It is also possible that limiting our assessment of MODS to the first 14 days of hospitalization may have led us to underestimate the incidence, as some patients may have developed MODS later in the hospitalization. Our selection criteria (hypotension and/or increased BD, major injuries, and blood transfusion requirement) made it more likely that hypoperfusion would occur early in the hospitalization period.
Finally, it is possible that StO 2 is merely a marker of hypoperfusion and that earlier recognition of the state of StO 2 would not lead to better patient outcome. We think, based on this study, considerable animal work, and anecdotal clinical experience, that NIRS technology holds great promise as a noninvasive continuous monitor of muscle oxygen saturation (Fig. 6 . At 12:55 she was moved to CT, case study). We think that further clinical familiarity with StO 2 monitoring will lead health care providers to utilize this device for early identification of injured patients at risk of shock and that this information may permit us to reduce patient morbidity and mortality.
In summary, the NIRS monitor was found to provide StO 2 information within the first hour of ED arrival to aid in the discrimination of patients who would later go on to develop MODS or die. This work is a well-designed, multi-center prospective study of the use of NIRS to predict death and organ dysfunction. Because of the blinded manner in which the data work was obtained, snapshots of tissue-oxygenation data were analyzed. The data could not be used to influence patient care.
It appears that the StO 2 was as good a predictor of organ dysfunction as BD or blood pressure. And it was even a better predictor of death. The advantage of this tool is that it's noninvasive. It can be applied in the emergency department or, more poignantly, in the field for EMS or military use. The most promising use for this technique really will be in dynamic volume resuscitation. StO 2 could give us the ability to better plan the use of crystalloid and blood products during early resuscitation. The possible benefits are reduction in the incidence of organ dysfunction and death in our trauma patients.
I really have just two questions for the authors. First, please comment on using the lowest tissue O 2 saturation during the first hour versus following trended information or real-time information, which you obviously were not able to do here.
Finally, have you moved on to the next step using this StO 2 data in real time? Please tell how you are using it or how you would use this data.
Dr. Stephen M. Cohn (San Antonio, Texas): We looked at both trended and lowest StO 2 . To simplify things, we used the lowest StO 2 values. These were StO 2 values collected during a 1-minute period. The values were essentially recorded every 3.5 seconds. That seemed to be the most clinically useful method of analyzing this data.
I believe that at all of the centers we're gaining some clinical familiarity. I've certainly used the device a few times in a few patients, and I found it to be helpful, but I think we're only at the beginning of our clinical familiarity with the device.
Dr. Martin Schreiber (Portland, Oregon): You decided to store your data categorically and you chose a MOD score of six to define multiple organ failure. Each organ system is scored from zero to four, which means that you may have only had two organs failing. Examples would include scores of four and two or three and three indicating two organ failures.
I'm curious as to why you chose six as the cutoff. Others have chosen nine, which means that you have to have three organs involved. So how did you choose a score of six for your categorical study?
Dr. Stephen M. Cohn: Because of the potential for brain injury we dropped the neurologic component of the MOD Score. We were looking at the other components of the Marshall score, not neurologic, and used six as it has been validated in some other trauma studies.
Dr. Richard Dutton (Baltimore, Maryland): Steve, what was your experience with the technical reliability of the device? Did you collect any data on how often it failed to work, or were there calibration errors or other things that might have caused you to withdraw a patient from the study?
